|
|
Volumn 51, Issue 5, 2001, Pages 437-441
|
|
Effect of MAO-A inhibition on the pharmacokinetics of almotriptan, an antimigraine agent in humans
a
|
|
Author keywords
Migraine; Monoamine oxidase; Pharmacokinetics; Serotonin agonist
|
|
Indexed keywords
ALMOTRIPTAN;
AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A;
ANTIMIGRAINE AGENT;
MOCLOBEMIDE;
MONOAMINE OXIDASE A INHIBITOR;
SUMATRIPTAN;
ZOLMITRIPTAN;
ADULT;
AREA UNDER THE CURVE;
ARTICLE;
BLOOD PRESSURE;
BODY TEMPERATURE;
BREATHING RATE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DRUG BLOOD LEVEL;
DRUG CLEARANCE;
DRUG EFFECT;
DRUG HALF LIFE;
DRUG TOLERABILITY;
DRUG URINE LEVEL;
ELECTROCARDIOGRAM;
ENZYME INHIBITION;
FEMALE;
HEADACHE;
HEART RATE;
HUMAN;
KIDNEY CLEARANCE;
MALE;
NORMAL HUMAN;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
STATISTICAL ANALYSIS;
TABLET;
ADOLESCENT;
ADULT;
CROSS-OVER STUDIES;
DRUG INTERACTIONS;
FEMALE;
HUMANS;
INDOLES;
MALE;
MIDDLE AGED;
MIGRAINE DISORDERS;
MOCLOBEMIDE;
MONOAMINE OXIDASE;
MONOAMINE OXIDASE INHIBITORS;
SEROTONIN AGONISTS;
TRYPTAMINES;
|
|
EID: 0034856955
PISSN: 03065251
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-2125.2001.01367.x Document Type: Article |
|
Times cited : (63)
|
|
References (18)
|
